ProShare Advisors LLC - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 152 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.27 and the average weighting 0.5%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$560,000
+100.0%
16,247
-3.0%
0.00%
+200.0%
Q2 2020$280,000
+70.7%
16,746
+47.6%
0.00%0.0%
Q1 2020$164,000
-75.2%
11,342
-42.7%
0.00%
-66.7%
Q4 2019$662,000
+43.6%
19,790
-10.1%
0.00%0.0%
Q3 2019$461,000
-3.2%
22,024
-3.7%
0.00%0.0%
Q2 2019$476,000
-17.8%
22,878
-11.6%
0.00%0.0%
Q1 2019$579,000
-5.5%
25,886
+1.1%
0.00%
-25.0%
Q4 2018$613,000
-22.9%
25,617
-12.1%
0.00%
-20.0%
Q3 2018$795,000
-1.9%
29,144
-3.2%
0.01%0.0%
Q2 2018$810,000
-17.1%
30,116
-1.9%
0.01%
-16.7%
Q1 2018$977,000
-20.8%
30,709
-5.9%
0.01%
-33.3%
Q4 2017$1,234,000
+61.1%
32,626
+5.7%
0.01%
+28.6%
Q3 2017$766,000
+28.7%
30,881
+6.7%
0.01%
+16.7%
Q2 2017$595,000
+6.8%
28,950
+12.9%
0.01%0.0%
Q1 2017$557,000
-15.5%
25,647
-20.4%
0.01%
-14.3%
Q4 2016$659,00032,2220.01%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Aisling Capital LLC 1,240,000$25,966,00057.34%
Foresite Capital Management II, LLC 2,605,499$54,559,00011.53%
Foresite Capital Management III, LLC 611,893$12,813,0004.89%
Palo Alto Investors LP 3,471,740$72,698,0004.84%
SANDERS MORRIS HARRIS LLC 486,906$10,196,0002.47%
Eventide Asset Management 3,084,000$64,579,0002.13%
Sofinnova Investments, Inc. 346,770$7,261,0000.66%
EMERALD ADVISERS, LLC 610,511$12,784,0000.60%
RICE HALL JAMES & ASSOCIATES, LLC 752,358$15,754,0000.56%
EMERALD MUTUAL FUND ADVISERS TRUST 587,464$12,301,0000.54%
View complete list of AIMMUNE THERAPEUTICS INC shareholders